{"AllianceGenome": "9864", "HGNC": "9864", "MIM": "180240", "_id": "5914", "_version": 1, "accession": {"genomic": ["AC080112.15", "AF283809.1", "AH007261.6", "AJ297538.1", "CH471152.1", "CP068261.2", "CS542437.1", "M61110.1", "M61111.1", "MW557603.1", "NC_000017.11", "NC_060941.1", "NG_027701.1", "S57794.1", "X56058.1"], "protein": ["AAB19602.2", "AAD13888.1", "AAF87249.1", "AAH08727.1", "AAH71733.1", "ACK86665.1", "ADZ17337.1", "ADZ17338.1", "BAF84894.1", "BAG35459.1", "BAG53585.1", "BAG64806.1", "CAA29787.1", "CAA29829.1", "CAA39533.1", "CAA41532.1", "CAG33719.1", "CAH56277.1", "CAM91168.1", "EAW60652.1", "EAW60653.1", "EAW60654.1", "EAW60655.1", "EAW60656.1", "EAW60657.1", "EAW60658.1", "NP_000955.1", "NP_001019980.1", "NP_001138773.1", "NP_001138774.1", "P10276.2", "QTY32077.1", "XP_005257609.1", "XP_005257610.1", "XP_005257611.1", "XP_011523397.1", "XP_011523398.1", "XP_047292462.1", "XP_047292463.1", "XP_047292464.1", "XP_054172813.1", "XP_054172814.1", "XP_054172815.1", "XP_054172816.1", "XP_054172817.1", "XP_054172818.1", "XP_054172819.1"], "rna": ["AK098172.1", "AK130192.1", "AK292205.1", "AK303868.1", "AK312564.1", "AL522713.3", "AL834159.1", "BC008727.2", "BC071733.1", "BG394590.1", "BM838347.1", "BM992549.1", "BY799725.2", "CB105313.1", "CR457438.1", "DA061829.1", "DA541711.1", "FJ487576.1", "HQ692826.1", "HQ692827.1", "NM_000964.4", "NM_001024809.4", "NM_001033603.1", "NM_001145301.3", "NM_001145302.3", "S50916.1", "X06538.1", "X06614.1", "X58685.1", "XM_005257552.6", "XM_005257553.2", "XM_005257554.2", "XM_011525095.2", "XM_011525096.2", "XM_047436506.1", "XM_047436507.1", "XM_047436508.1", "XM_054316838.1", "XM_054316839.1", "XM_054316840.1", "XM_054316841.1", "XM_054316842.1", "XM_054316843.1", "XM_054316844.1"], "translation": [{"protein": "XP_047292462.1", "rna": "XM_047436506.1"}, {"protein": "ACK86665.1", "rna": "FJ487576.1"}, {"protein": "XP_011523397.1", "rna": "XM_011525095.2"}, {"protein": "XP_047292464.1", "rna": "XM_047436508.1"}, {"protein": "NP_001138773.1", "rna": "NM_001145301.3"}, {"protein": "XP_054172817.1", "rna": "XM_054316842.1"}, {"protein": "AAH71733.1", "rna": "BC071733.1"}, {"protein": "BAG64806.1", "rna": "AK303868.1"}, {"protein": "ADZ17337.1", "rna": "HQ692826.1"}, {"protein": "XP_005257609.1", "rna": "XM_005257552.6"}, {"protein": "XP_054172813.1", "rna": "XM_054316838.1"}, {"protein": "ADZ17338.1", "rna": "HQ692827.1"}, {"protein": "NP_001019980.1", "rna": "NM_001024809.4"}, {"protein": "CAG33719.1", "rna": "CR457438.1"}, {"protein": "XP_054172815.1", "rna": "XM_054316840.1"}, {"protein": "AAB19602.2", "rna": "S50916.1"}, {"protein": "XP_005257610.1", "rna": "XM_005257553.2"}, {"protein": "CAA29787.1", "rna": "X06538.1"}, {"protein": "XP_054172818.1", "rna": "XM_054316843.1"}, {"protein": "NP_000955.1", "rna": "NM_000964.4"}, {"protein": "CAA29829.1", "rna": "X06614.1"}, {"protein": "XP_054172816.1", "rna": "XM_054316841.1"}, {"protein": "XP_054172819.1", "rna": "XM_054316844.1"}, {"protein": "NP_001138774.1", "rna": "NM_001145302.3"}, {"protein": "CAH56277.1", "rna": "AL834159.1"}, {"protein": "BAG35459.1", "rna": "AK312564.1"}, {"protein": "CAA41532.1", "rna": "X58685.1"}, {"protein": "XP_047292463.1", "rna": "XM_047436507.1"}, {"protein": "XP_054172814.1", "rna": "XM_054316839.1"}, {"protein": "XP_005257611.1", "rna": "XM_005257554.2"}, {"protein": "BAG53585.1", "rna": "AK098172.1"}, {"protein": "XP_011523398.1", "rna": "XM_011525096.2"}, {"protein": "BAF84894.1", "rna": "AK292205.1"}, {"protein": "AAH08727.1", "rna": "BC008727.2"}]}, "alias": ["NR1B1", "RAR", "RARalpha"], "ensembl": {"gene": "ENSG00000131759", "protein": ["ENSP00000254066", "ENSP00000377643", "ENSP00000377648", "ENSP00000377649", "ENSP00000389993", "ENSP00000462514", "ENSP00000464287"], "transcript": ["ENST00000254066", "ENST00000394081", "ENST00000394086", "ENST00000394089", "ENST00000420042", "ENST00000425707", "ENST00000475125", "ENST00000577646", "ENST00000579727", "ENST00000582914"], "translation": [{"protein": "ENSP00000464287", "rna": "ENST00000577646"}, {"protein": "ENSP00000254066", "rna": "ENST00000254066"}, {"protein": "ENSP00000377649", "rna": "ENST00000394089"}, {"protein": "ENSP00000389993", "rna": "ENST00000425707"}, {"protein": "ENSP00000377648", "rna": "ENST00000394086"}, {"protein": "ENSP00000377643", "rna": "ENST00000394081"}, {"protein": "ENSP00000462514", "rna": "ENST00000475125"}], "type_of_gene": "protein_coding"}, "entrezgene": "5914", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 12.7777902816, "exp_mis": 182.053993974, "exp_syn": 87.8844486332, "lof_z": 3.26381557330969, "mis_z": 3.59077638029507, "mu_lof": 9.78277118733e-07, "mu_mis": 1.81437566906e-05, "mu_syn": 8.67898467747e-06, "n_lof": 1.0, "n_mis": 83.0, "n_syn": 101.0, "p_li": 0.934197317282478, "p_null": 6.31498422709868e-05, "p_rec": 0.0657395328752509, "syn_z": -0.867321145040882}, "bp": 1389, "cds_end": 38512478, "cds_start": 38487470, "n_exons": 8, "nonpsych": {"exp_lof": 11.4188228852, "exp_mis": 164.630126752, "exp_syn": 79.3976027178, "lof_z": 3.02802856628281, "mis_z": 3.64132270525797, "mu_lof": 9.78277118733e-07, "mu_mis": 1.81437566906e-05, "mu_syn": 8.67898467747e-06, "n_lof": 1.0, "n_mis": 72.0, "n_syn": 96.0, "p_li": 0.907158679336714, "p_null": 0.000185316645383114, "p_rec": 0.0926560040179025, "syn_z": -1.17308832813248}, "nontcga": {"exp_lof": 11.7413060619, "exp_mis": 167.475425159, "exp_syn": 80.8394412963, "lof_z": 3.09228936054563, "mis_z": 3.63708233901237, "mu_lof": 9.78277118733e-07, "mu_mis": 1.81437566906e-05, "mu_syn": 8.67898467747e-06, "n_lof": 1.0, "n_mis": 73.0, "n_syn": 95.0, "p_li": 0.909333389041561, "p_null": 0.000142806036533863, "p_rec": 0.0905238049219053, "syn_z": -0.997220134911093}, "transcript": "ENST00000254066.5"}, "exons": [{"cdsend": 40356226, "cdsstart": 40331218, "chr": "17", "position": [[40309179, 40309286], [40330856, 40331396], [40348315, 40348464], [40349783, 40349925], [40351909, 40352070], [40352330, 40352507], [40354301, 40354506], [40355262, 40355421], [40356008, 40357643]], "strand": 1, "transcript": "NM_000964", "txend": 40357643, "txstart": 40309179}, {"cdsend": 40356226, "cdsstart": 40342704, "chr": "17", "position": [[40342165, 40342867], [40348315, 40348464], [40349783, 40349925], [40351909, 40352070], [40352330, 40352507], [40354301, 40354506], [40355262, 40355421], [40356008, 40357643]], "strand": 1, "transcript": "NM_001024809", "txend": 40357643, "txstart": 40342165}, {"cdsend": 40356226, "cdsstart": 40331218, "chr": "17", "position": [[40318244, 40318448], [40330856, 40331396], [40348315, 40348464], [40349783, 40349925], [40351909, 40352070], [40352330, 40352507], [40354301, 40354506], [40355262, 40355421], [40356008, 40357643]], "strand": 1, "transcript": "NM_001145301", "txend": 40357643, "txstart": 40318244}, {"cdsend": 40356226, "cdsstart": 40331218, "chr": "17", "position": [[40318244, 40318448], [40330856, 40331396], [40351909, 40352070], [40352330, 40352507], [40354301, 40354506], [40355262, 40355421], [40356008, 40357643]], "strand": 1, "transcript": "NM_001145302", "txend": 40357643, "txstart": 40318244}], "exons_hg19": [{"cdsend": 38512478, "cdsstart": 38487470, "chr": "17", "position": [[38465431, 38465538], [38487108, 38487648], [38504567, 38504716], [38506035, 38506177], [38508161, 38508322], [38508582, 38508759], [38510553, 38510758], [38511514, 38511673], [38512260, 38513895]], "strand": 1, "transcript": "NM_000964", "txend": 38513895, "txstart": 38465431}, {"cdsend": 38512478, "cdsstart": 38498956, "chr": "17", "position": [[38498417, 38499119], [38504567, 38504716], [38506035, 38506177], [38508161, 38508322], [38508582, 38508759], [38510553, 38510758], [38511514, 38511673], [38512260, 38513895]], "strand": 1, "transcript": "NM_001024809", "txend": 38513895, "txstart": 38498417}, {"cdsend": 38512478, "cdsstart": 38487470, "chr": "17", "position": [[38474496, 38474700], [38487108, 38487648], [38504567, 38504716], [38506035, 38506177], [38508161, 38508322], [38508582, 38508759], [38510553, 38510758], [38511514, 38511673], [38512260, 38513895]], "strand": 1, "transcript": "NM_001145301", "txend": 38513895, "txstart": 38474496}, {"cdsend": 38512478, "cdsstart": 38487470, "chr": "17", "position": [[38474496, 38474700], [38487108, 38487648], [38508161, 38508322], [38508582, 38508759], [38510553, 38510758], [38511514, 38511673], [38512260, 38513895]], "strand": 1, "transcript": "NM_001145302", "txend": 38513895, "txstart": 38474496}], "generif": [{"pubmed": 11106752, "text": "two critical hits for promyelocytic leukemia"}, {"pubmed": 11891284, "text": "UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia"}, {"pubmed": 11929748, "text": "Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways."}, {"pubmed": 12009305, "text": "Results show that both RARalpha and RARbeta are mediators in the anticancer function of All-trans retinoic acid via AP-1 activity inhibition."}, {"pubmed": 12060771, "text": "induces acute promyelocytic leukemia in a mouse model"}, {"pubmed": 12080444, "text": "obesity is associated with an inverse relationship between peroxisome proliferator-activated receptor gamma and RARalpha expressions in subcutaneous adipose tissue"}, {"pubmed": 12193472, "text": "the silencing of the RAR alpha2 promoter by hypermethylation may play a contributory role in the dysregulation of RA signaling in mammary tumorigenesis."}, {"pubmed": 12213824, "text": "Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of the receptor."}, {"pubmed": 12393611, "text": "IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with recombinant human retinoic acid receptors in an IL-3-dependent manner."}, {"pubmed": 12399530, "text": "In normal epithelium, both RAR-alpha and -gamma present with minimal nuclear accumulation. Increased in luminal epithelial nuclei in prostatic intra-epithelial neoplasia"}, {"pubmed": 12420222, "text": "RAR pan-agonists and the RARalpha-selective agonist Am580, but not RXR agonists, stimulate the expression of SOX9 in a wide variety of retinoid-inhibited breast cancer cell lines."}, {"pubmed": 12468549, "text": "mutational analysis of human retinoic acid receptor alpha ligand binding domain"}, {"pubmed": 12505266, "text": "Cryptic translocation of PML/RARA on 17q. A rare event in acute promyelocytic leukemia."}, {"pubmed": 12810556, "text": "endocrine molecule retinoic acid, and its receptor RARs play a critical role in alveolarization during the neonatal period of the lung."}, {"pubmed": 12835288, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12935958, "text": "REVIEW the biology of RARalpha, and the RARalpha fusion proteins created in APL and the normal forms of the partner proteins"}, {"pubmed": 14559998, "text": "data suggest that Sp110b is a transcriptional cofactor negatively regulating retinoic acid receptor alpha-mediated transcription"}, {"pubmed": 14592536, "text": "RARA has a distinct role and functional mode in mediating tretinoin-induced signalling."}, {"pubmed": 14691372, "text": "In a 9-cis retinoic acid-dependent fashion in cells in vitro, retinoic acid receptor alpha isoform stimulates the expression of reporter constructs containing the site that binds aldehyde dehydrogenase-2."}, {"pubmed": 14705796, "text": "depletion of vitamin A and retinoid receptors by UV irradiation, together with unchanged or even increased c-Jun levels, might seriously interfere with retinoid signaling and thus promote future tumor development, especially in keratinocytes."}, {"pubmed": 14737102, "text": "role in development of myelodi leukemia with promyelocytic features"}, {"pubmed": 15171703, "text": "Results show an increased DNA binding of the retinoic acid receptor alpha/retinoid X receptor alpha heterodimer and the stability of nuclear localization of this heterodimer, which facilitates signal transduction."}, {"pubmed": 15246741, "text": "intrinsic ageing of human skin is accompanied by significant elevation in the content of RAR alpha"}, {"pubmed": 15255287, "text": "Increase in expression of RARalpha is associated with esophageal squamous cell carcinomas"}, {"pubmed": 15337793, "text": "retinoic acid receptor-alpha is synthesized by activated polymorphonuclear leukocytes"}, {"pubmed": 15601827, "text": "PML-retinoic acid receptor alpha activities are regulated by neutrophil elastase in early myeloid cells"}, {"pubmed": 15635645, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15746941, "text": "CDDO-Im downregulates RARA expression in acute promyelocytic leukemic cells."}, {"pubmed": 15809060, "text": "inhibition of monocyte differentiation all contribute to the oncogenic activity of PML-RARalpha"}, {"pubmed": 15831516, "text": "analysis of estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells"}, {"pubmed": 15870697, "text": "Transient transfection of either all-trans-retinoic acid (ATRA) receptor alpha or estrogen receptor alpha expression vectors increased cellular retinoic acid binding protein II expression in MDA-MB-231 cells"}, {"pubmed": 16085646, "text": "all-trans-retinoic acid, an RARalpha ligand, regulates IFNgamma-induced IRF-1 by affecting multiple components of the IFNgamma signaling pathway, from the plasma membrane to the nuclear transcription factors"}, {"pubmed": 16113082, "text": "loss of one copy of PU.1 through deletion, plus down-regulation of the residual allele caused by PML-RARalpha expression, synergizes to expand myeloid progenitors susceptible to transformation, increasing the penetrance of acute promyelocytic leukemia"}, {"pubmed": 16203797, "text": "p16INK4a, RARbeta, and MGMT expression is activated by genistein and related soy isoflavones partially through a direct inhibition of DNA methyltransferase"}, {"pubmed": 16239915, "text": "RARA is the first myeloid-specific transcription factor shown to be dysregulated by both translocation and aberrant methylation"}, {"pubmed": 16289102, "text": "All trans retinoic acid suppresses 24-hydroxylase expression through RARalpha-dependent signaling pathway and can enhance vitamin D action in suppression of cell growth."}, {"pubmed": 16311697, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16417524, "text": "protein kinase b interacts with RARalpha and phosphorylates the Ser96 residue of its DNA-binding domain."}, {"pubmed": 16424870, "text": "Ski seems to be involved in the blocking of differentiation in AML via inhibition of RARalpha signaling"}, {"pubmed": 16432238, "text": "PML-RARalpha functions by recruiting an HDAC3-MBD1 complex that contributes to the establishment and maintenance of the silenced chromatin state"}, {"pubmed": 16449642, "text": "permanent transcriptional silencing is mediated by the association of PML-RAR with chromatin-modifying enzymes and by recruitment of the histone methyltransferase SUV39H1, responsible for trimethylation of lysine 9 of histone H3"}, {"pubmed": 16480812, "text": "The aryl hydrocarbon receptor activates the retinoic acid receptoralpha through SMRT antagonism"}, {"pubmed": 16504291, "text": "The NPM-RAR localizes diffusely throughout the nucleoplasm. NPM-RAR does not alter the localization of PML in transfected HeLa cells, and does not associate with PML in vitro."}, {"pubmed": 16540467, "text": "analysis of cytoplasmic function of mutant promyelocytic leukemia (PML) and PML-retinoic acid receptor-alpha"}, {"pubmed": 16606617, "text": "ASXL1 is a novel coactivator of RAR that cooperates with SRC-1"}, {"pubmed": 16630218, "text": "frequencies of the PML-RARalpha transcripts and subtypes in a series of 32 APL patients from Northeast Brazil"}, {"pubmed": 16728697, "text": "prevalence of anti-RARalpha antibodies in patients with acute promyelocytic leukemia"}, {"pubmed": 16769902, "text": "providing an explanation for how cAMP synergizes with retinoic acid for transcription"}, {"pubmed": 16797070, "text": "The PML-RARA fusions can be identified by molecular analyses such as reverse transcriptase-polymerase chain reaction (PCR) and fluorescence in situ hybridization (FISH)."}, {"pubmed": 17005281, "text": "liganded RXRalpha is a potent activator of endogenous SOX3 protein expression"}, {"pubmed": 17244680, "text": "AML1/ETO participates in a protein complex with the RA receptor alpha (RARalpha) at RA regulatory regions on RARbeta2."}, {"pubmed": 17252005, "text": "Selection of the RARalpha locus in leukemia patients occursas the consequence of the nuclear architecture of the different RAR loci."}, {"pubmed": 17272513, "text": "our results indicate that activator Sp1 and repressor RXRalpha:RARalpha act in concert to regulate MRP3 expression."}, {"pubmed": 17272867, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17451432, "text": "RARalpha/RXRalpha heterodimer is involved in the differential regulation of the GnRH II gene in neuronal and placental cells"}, {"pubmed": 17456381, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17475621, "text": "the hormone-independent association between PML-RARalpha and coactivators contributes to its ability to regulate gene expression"}, {"pubmed": 17595318, "text": "Ligand binding to RAR would play a major role in the assembly and intracellular location of a signaling complex involving RAR and the subunits of PI3K."}, {"pubmed": 17611697, "text": "Am-80-induced cell-type non-specific growth inhibition is mediated by TGF-beta2, where the total mass of RARalpha could be an important regulatory factor in hematologic malignant cells"}, {"pubmed": 17628022, "text": "Retinoic-acid-induced RAR-CAK signaling events appear to proceed intrinsically during granulocytic development of normal primitive hematopoietic cells. ALDH-governed RA availability may mediate this process by initiating RAR-CAK signaling."}, {"pubmed": 17656367, "text": "p21WAF1/CIP1 is a common transcriptional target of retinoid receptors RAR and RXR"}, {"pubmed": 17761950, "text": "demonstrate the distinct regulatory mechanisms of p300 and TR3 on RXRalpha acetylation"}, {"pubmed": 17943164, "text": "PML/RAR gene cytogenetic abnormalities in APL"}, {"pubmed": 17960617, "text": "Promoter hypermethylation of RAR alpha is associated with prostate cancer progression"}, {"pubmed": 17991421, "text": "These results would shed new insights for the molecular mechanisms of PML-RARalpha-associated leukemogenesis."}, {"pubmed": 17993618, "text": "Mechanisms responsible for deregulation of gene expression in acute myeloid leukemia support the notion that diminished RARA expression contributes to leukemogenesis."}, {"pubmed": 18000064, "text": "supports an active role for PLZF and RARalpha-PLZF in leukemogenesis, identifies up-regulation of CRABPI"}, {"pubmed": 18024792, "text": "The transcription factor PML-RARalpha regulates key cancer-related genes and pathways by inducing a repressed chromatin formation on its direct genomic target genes."}, {"pubmed": 18180299, "text": "CCR4 plays a role in the regulation of certain endogenous RARalpha target genes and RCD1 and CCR4 might mediate their function through their interaction with NIF-1"}, {"pubmed": 18212063, "text": "Topoisomerase II beta associates with & negatively modulates RARalpha transcriptional activity. Increased levels of and association with TopoIIbeta cause resistance to retinoic acid in acute promyelocytic leukemia cell lines."}, {"pubmed": 18305945, "text": "IN COLONIC SERRATED ADENOMAS Three genes (TNFRSF10A, BENE, RARA) with strongly significant expression intensities in the oligonucleotide microarray"}, {"pubmed": 18416830, "text": "a role for RAR-alpha engagement in the regulation of genes and proteins involved with human T cell activation and type 2 cytokine production"}, {"pubmed": 18636556, "text": "PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells."}, {"pubmed": 18660489, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18996102, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19029980, "text": "whereas transcriptional activation of PML-RARA is likely to control differentiation, its catabolism triggers leukemia-initiating cell eradication and long-term remission of mouse acute promyelocytic leukemia"}, {"pubmed": 19100514, "text": "Acute promyelocytic leukemia with insertion of PML exon 7 a and partial deletion of exon 3 of RARA is reported."}, {"pubmed": 19106195, "text": "These data indicate that the RAR/RXR heterodimer is a critical regulator of human hematopoietic stem cell (HSC) differentiation, and pharmacological modulation of RXR signaling prevents the loss of human HSCs that otherwise occurs in short-term culture."}, {"pubmed": 19128831, "text": "First documented case of acute promyelocytic leukemia with an RARalpha submicroscopic deletion which is not associated with X-RARalpha fusion."}, {"pubmed": 19144697, "text": "Data show that retinoids induce gene expression of ADAM10 and alpha-secretase activity by nonpermissive retinoid acid receptor/retinoid X receptor (RAR/RXR) heterodimers, whereby alpha- and beta-isotypes of RAR play a major role."}, {"pubmed": 19173001, "text": "Derangement/lack of a critical factor necessary for RARalpha function induces epigenetic repression of a RA-regulated gene network downstream of RARalpha, with major pleiotropic biological outcomes."}, {"pubmed": 19224461, "text": "Identification of PML/RARalpha fusion gene transcripts that showed no t(15;17) with conventional karyotyping and fluorescent in situ hybridization"}, {"pubmed": 19322209, "text": "Knock-in human PML-RARalpha alone can confer properties of self-renewal to committed murine hematopoietic progenitors before the onset of disease."}, {"pubmed": 19341714, "text": "Ski can stabilize RARalpha and HDAC3 thus Ski represses retinoic acid signaling by stabilizing corepressor complex."}, {"pubmed": 19458357, "text": "Knockdown of RARalpha2 but not RARalpha1 induced significant MM cell death and growth inhibition; and overexpressing RARalpha2 activated STAT3 and MEK and ERK signaling pathways."}, {"pubmed": 19465599, "text": "RARalpha-deficient germ-cell stem cells were able to repopulate germ-cell-depleted wild-type testes and initiate spermatogenesis; however, improper cellular associations and abnormal sperm formation were observed."}, {"pubmed": 19563758, "text": "Study found that RARalpha/RARgamma exhibit extensive colocalization of their genomic binding regions with ERalpha in the vicinity of genes that are antagonistically regulated by estrogen and RA."}, {"pubmed": 19626135, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19626135, "text": "Variations in the nucleotide sequence of RARA are not associated with myopia, hypermetropia, or ocular biometric measures."}, {"pubmed": 19628791, "text": "Induction of transglutaminase 2 by a liver X receptor/retinoic acid receptor alpha pathway increases the clearance of apoptotic cells by human macrophages."}, {"pubmed": 19732752, "text": "TNIP1 interacts with liganded RARalpha and RARgamma but acts as a corepressor of their activity."}, {"pubmed": 19799861, "text": "redox regulation function of thioredoxin glutathione reductase protects the DNA-binding activity of RAR against cellular ROS damage."}, {"pubmed": 19828696, "text": "Data show that induction of CCL2 and CCL24 was directly mediated by ligand-activated retinoic acid receptors."}, {"pubmed": 19855079, "text": "Data show that PLZF-RARalpha binds to a region of the c-MYC promoter, suggesting that PLZF-RARalpha may act as a dominant-negative version of PLZF by affecting the regulation of shared targets."}, {"pubmed": 19863682, "text": "alternative splicing of PML/RARalpha transcripts might be involved in nonsense-mediated decay"}, {"pubmed": 19884280, "text": "Retinoic acid receptor alpha is the major isoform responsible for CYP26A1 induction."}, {"pubmed": 19902255, "text": "Data show significant associations between SNPs in RARA, RARB, TOP2B and RARG, RXRA, TLR3, TRIM5 and RIG-I genes and rubella virus-specific cytokine immune responses."}, {"pubmed": 19902255, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19937600, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19965660, "text": "Leukemic transformation by acute promyelocytic leuckemia fusion protein PRKAR1A-RARalpha is critically dependent on RXRalpha."}, {"pubmed": 20080953, "text": "RAR alpha as an essential component of the estrogen receptor-alpha (ER)- complex, potentially by maintaining ER-cofactor interactions, and suggest that different nuclear receptors can cooperate for effective transcriptional activity in breast cancer cells"}, {"pubmed": 20133705, "text": "PML/RARalpha transactivates the TF promoter through an indirect interaction with an element composed of a GAGC motif and the flanking nucleotides, independent of AP-1 binding."}, {"pubmed": 20155840, "text": "We studied 21 PML-RARA positive/RARA-PML negative cases by bubble PCR and multiplex long template PCR to identify the genomic breakpoints."}, {"pubmed": 20159609, "text": "PML-RARalpha/RXR functions as a local chromatin modulator and that specific recruitment of histone deacetylase activities to genes important for hematopoietic differentiation, RAR signaling, and epigenetic control is crucial to its transforming potential."}, {"pubmed": 20159610, "text": "Selective targeting of PU.1-regulated genes by PML/RARalpha is a critical mechanism for the pathogenesis of acute promyelocytic leukemia(APL)."}, {"pubmed": 20185965, "text": "Role of RARA in differentiation of human mesenchymal stem cells is reported."}, {"pubmed": 20190807, "text": "Retinoic acid-suppressed phosphorylation of RARalpha induces FGF8f expression to mediate differentiation response pathway in U2OS osteosarcoma cells."}, {"pubmed": 20346360, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20354914, "text": "RAR, RXR and VDR are expressed in human fetal pancreatic progenitor cells."}, {"pubmed": 20543827, "text": "The basal repressive activity of RAR is conferred by an extended beta-strand that forms an antiparallel beta-sheet with specific corepressor residues."}, {"pubmed": 20544846, "text": "RARA breakpoints are associated with acute promyelocytic leukemia."}, {"pubmed": 20572854, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20574048, "text": "autophagic degradation contributes significantly both to the basal turnover as well as the therapy-induced proteolysis of PML/RARA"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20634891, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20736163, "text": "CART1 might be a cytoplasmic, testis-specific derepressor of RAR"}, {"pubmed": 20804918, "text": "RARA amplification in hematologic malignancies may serve as an independent prognostic factor."}, {"pubmed": 20807888, "text": "BCOR is a fusion partner of RARA in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia. BCOR-RARA possesses common features with other RARA fusion proteins."}, {"pubmed": 21053424, "text": "Tribles homolog 1 (Trib1) functions as a negative regulator of Retinoic acid receptor-alpha."}, {"pubmed": 21150871, "text": "RARa-mediated signaling acts as an endogenous protective pathway to slow the progression of kidney disease, and selective activation of the RARa receptor may be a promising treatment option for patients with HIV-associated nephropathy."}, {"pubmed": 21187718, "text": "Autophagy regulates myeloid cell differentiation by p62/SQSTM1-mediated degradation of PML-RARalpha oncoprotein"}, {"pubmed": 21190992, "text": "Rara haploinsufficiency (like Pml haploinsufficiency and RARA-PML) can cooperate with PML-RARA to influence the pathogenesis of APL in mice, but that PML-RARA is the t(15;17) disease-initiating mutation."}, {"pubmed": 21245861, "text": "New insights that arose from these studies, in particular focussing on newly identified PML-RARalpha target genes, its interplay with RXR and deregulation of epigenetic modifications."}, {"pubmed": 21254357, "text": "One variant in the RARA gene (rs12051734), three variants in the RARB gene (rs6799734, rs12630816, rs17016462), and one variant in the RARG gene (rs3741434) were found to be statistically significant at p < 0.05 as risk factors for meningomyelocele."}, {"pubmed": 21255834, "text": "Phenotype onset is correlated with NuMA-RARalpha copy number; mice with higher copy number developing disease later than those with lower copy number."}, {"pubmed": 21262770, "text": "G-CSF restores RARalpha recruitment to target gene promoters through the activation of the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) pathway and the subsequent derepression of chromatin."}, {"pubmed": 21272161, "text": "data indicate that JNK activation by oxidative stress suppresses retinoid signaling through proteasomal degradation of RARalpha"}, {"pubmed": 21310922, "text": "Depletion of S100A10 by RNA interference effectively blocked the enhanced fibrinolytic activity observed after induction of the PML-RAR-alpha oncoprotein"}, {"pubmed": 21364283, "text": "physiologic PML-RARA expression was sufficient to direct a hematopoietic progenitor self-renewal program in vitro and in vivo"}, {"pubmed": 21451111, "text": "both CD1d and CD1c are upregulated by RARalpha signaling in human B cells"}, {"pubmed": 21613260, "text": "Data indicate that PML-RARA (PR)-WT in the soluble fraction was transferred to the insoluble fraction after treatment with AsO, but PR-B/L-mut was stably detected in fractions both with and without AsO."}, {"pubmed": 21736617, "text": "Data show that RORalpha is mainly located in human Jurkat T-cell nucleus, and it is co-immunoprecipitated with melatonin."}, {"pubmed": 21803845, "text": "PMLRARalpha binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivo."}, {"pubmed": 21934296, "text": "investigation of DNA breakpoints in PML-RARalpha V-form fusion transcripts in 7 Chinese acute promyelocytic leukemia patients (out of total of 134 APL patients); in 5 of these cases, the V-form transcripts were unique (i.e., not described previously)"}, {"pubmed": 21949683, "text": "Data show that TEL as a transcriptional repressor of Retinoic acid receptor (RAR) signaling by its direct binding to both RAR and its dimerisation partner, the retinoid x receptor (RXR) in a ligand-independent fashion."}, {"pubmed": 22022577, "text": "The present study further demonstrated that GRP75 translocates into the nucleus and physically interacts with retinoid receptors (RARalpha and RXRalpha) to augment retinoic acid-elicited neuronal differentiation."}, {"pubmed": 22045737, "text": "Coregulator exchange and chromatin binding affect retinoic acid receptor mobility."}, {"pubmed": 22056876, "text": "a novel paradigm in which a fraction of the cellular RARalpha pool is present in membrane lipid rafts, where it forms complexes with G protein alpha Q (Galphaq) in response to RA"}, {"pubmed": 22167334, "text": "PML-RARa bcr1 fusion is not responsible for colorectal tumor development."}, {"pubmed": 22181564, "text": "APL lacking an RARalpha rearrangement may possess an alternative mechanism mediating the differentiation block that causes APL."}, {"pubmed": 22182411, "text": "These findings suggest that TRIM32 functions as one of the coactivators for RARalpha-mediated transcription in acute promyelogenous leukemia cells."}, {"pubmed": 22498738, "text": "HK3 is: (1) directly activated by PU.1, (2) repressed by PML-RARA, and (3) functionally involved in neutrophil differentiation and cell viability of acute promyelocytic leukemia cells."}, {"pubmed": 22982005, "text": "analysis of a cryptic PML-RARA translocation in a patient with acute promyelocytic leukemia [case report]"}, {"pubmed": 23064648, "text": "The RAR-dependent and Pol III-dependent DR2 Alu transcriptional events in stem cells functionally complement the Pol II-dependent neuronal transcriptional program."}, {"pubmed": 23064710, "text": "detection of double-stranded polymerase chain reaction (PCR) products of PML/RARalpha fusion gene in acute promyelocytic leukemia (APL)"}, {"pubmed": 23102699, "text": "Results define PARG as a coactivator regulating chromatin remodeling during retinoic acid receptor-dependent gene expression."}, {"pubmed": 23271512, "text": "STAT5-RARA positive acute promyelocytic leukemia variant is unresponsive to both all trans retinoic acid and arsenic trioxide."}, {"pubmed": 23448850, "text": "Studies indicate that initiation of leukemogenesis by PML-RARalpha occurs independently from DNA methylation."}, {"pubmed": 23474897, "text": "Data indicate antagonism to retinoic acid receptor alpha (RARalpha) for both synthesized chromene analog compounds."}, {"pubmed": 23612809, "text": "The objective was to describe the frequency of molecular subtypes of PML/RARalpha in patients with acute promyelocytic leukemia (APL) and their distribution according to risk of recurrence and cytomorphology"}, {"pubmed": 23770850, "text": "PML/RARalpha suppresses PU.1-dependent activation of the proteasome immunosubunits in acute promyelocytic leukemia."}, {"pubmed": 23775127, "text": "CTBP2 is a transcriptional cofactor for RXR-alpha/RAR-alpha."}, {"pubmed": 23782583, "text": "an association between polymorphisms of RARA gene and some of some common adverse effects of oral isotretinoin in acne patients"}, {"pubmed": 23847194, "text": "RARalpha2 has a role in determining myeloma stem cell features in mouse and human cells"}, {"pubmed": 23868472, "text": "Retinoic acid receptor alpha may be a novel therapeutic target and a predictive factor for estrogen receptor alpha-positive breast cancer patients treated with adjuvant tamoxifen."}, {"pubmed": 23898169, "text": "RARalpha-PLZF fusion protein inhibits myeloid cell differentiation through interactions with C/EBPalpha tethered to DNA in acute promyelocytic leukemia."}, {"pubmed": 23927396, "text": "These results indicate that NPM-RAR, not RAR-NPM, is the prime mediator of myeloid differentiation arrest in t(5;17) APL."}, {"pubmed": 23969901, "text": "Differences in RAR and RXR subtype mRNA expression patterns in various PTCs may contribute to the immunochemistry data available, and may thus find exploitation in clinical oncology, particularly in the differential diagnosis of thyroid neoplasms."}, {"pubmed": 24038216, "text": "The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPalpha during granulocytic differentiation but repressed by PML-RARalpha in APL."}, {"pubmed": 24050824, "text": "The current status of knowledge indicates that there might be inter- or overlapping actions between PPARg and RARs, and there might be an association of PPARg/RARs(RARa, RARb, and RARg) with renal diseases"}, {"pubmed": 24183235, "text": "RXR interaction is necessary for NPM-RAR-mediated myeloid maturation arrest."}, {"pubmed": 24264050, "text": "OSTbeta is a target of RARalpha-mediated (by binding to DR5 response element) gene regulation pathways"}, {"pubmed": 24394593, "text": "provide evidence for the existence of a functional ternary complex containing TDG, CBP and activated RARalpha"}, {"pubmed": 24516348, "text": "Down-regulation of NLS-RARalpha expression inhibited the proliferation and induced the differentiation of HL-60 cells. On the contrary, over-expression of NLS-RARa promoted proliferation and reduced the ATRA-induced differentiation of HL-60 cells."}, {"pubmed": 24608861, "text": "E2F1 is found to downregulate retinoic acid receptor alpha (RARalpha), a key factor determines the effectiveness of all-trans retinoic acid."}, {"pubmed": 24711541, "text": "PML-RARalpha cooperates with HIF-1alpha to activate a pro-leukemogenic program."}, {"pubmed": 24806185, "text": "The presence of a mutation in the arsenic-binding domain of PML-RARA led to arsenic resistance in patients with acute promyelocytic leukemia."}, {"pubmed": 24819975, "text": "SUMO-1 modification of RARA is a potent mechanism for balancing proliferation and differentiation by controlling the stability of RARA in cancer cells."}, {"pubmed": 24992177, "text": "RARalpha might be involved in the pathogenesis of varicocele as its expression is reduced in pathologic samples."}, {"pubmed": 25033841, "text": "This study identifies a novel mechanism through which NPM-RAR affects leukemogenesis"}, {"pubmed": 25071154, "text": "Results show that UTX interacts with the retinoic acid receptor alpha (RARalpha) and this interaction is essential for proper differentiation of leukemic U937 cells in response to retinoic acid."}, {"pubmed": 25275592, "text": "CDKN2D repression by PML/RARalpha disrupts both cell proliferation and differentiation in the pathogenesis of acute promyelocytic leukemia."}, {"pubmed": 25300573, "text": "These results suggest that overexpression of RARA enhances malignant transformation during mammary tumorigenesis."}, {"pubmed": 25550158, "text": "Data indicate that retinoic acid receptor (RAR) is crucial for regulating sodium taurocholate cotransporting polypeptide (NTCP) expression that determines permissiveness to hepatitis B virus (HBV) infection."}, {"pubmed": 25680531, "text": "Human miR-138 promotes tau phosphorylation by directly targeting the RARA and the associated GSK-3beta pathway."}, {"pubmed": 25791120, "text": "NPM-RAR binding to TRADD selectively inhibits caspase activation, while allowing activation of NFkappaB and JNK"}, {"pubmed": 26026090, "text": "bortezomib impairs the UPS that controls normal protein homeostasis by causing excessive accumulation of PML-RARA augmenting ER stress and leading to acute promyelocytic leukemia cell death"}, {"pubmed": 26041820, "text": "Data show that the tumor suppressor RASSF1A is a direct target of the PML/RARalpha-regulated microRNAs miR-181a/b cluster."}, {"pubmed": 26088929, "text": "our findings challenge the predominant model in the field and we propose that PML/RARA initiates leukemia by subtly shifting cell fate decisions within the promyelocyte compartment."}, {"pubmed": 26213848, "text": "Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARalpha protein degradation in acute promyelocytic leukemia."}, {"pubmed": 26294332, "text": "The PML-region mutations were associated with response to Arsenic trioxide-based therapy (P < 0.0001), number of relapses (P = 0.001), and early relapse (P = 0.013)in acute promyelocytic leukemia patients."}, {"pubmed": 26537301, "text": "Novel insight into the functional difference of acquired mutations of PML-RARA both in vitro and in the clinical setting."}, {"pubmed": 26728137, "text": "ATRA dramatically down regulated RARalpha protein levels and led to more DNA damage and ultimately resulted in the synergism of these two agents"}, {"pubmed": 26743651, "text": "RAI1 polymorphisms rs4925102 and rs9907986 are predicted to disrupt the binding of retinoic acid RXR-RAR receptors and the transcription factor DEAF1, respectively, in Smith-Magenis and Potocki-Lupski syndromes patients."}, {"pubmed": 26754533, "text": "Work identifies the TP53 tumor suppressor as a novel target through which NPM1-RARA impacts leukemogenesis."}, {"pubmed": 26818829, "text": "The classical counterpart of RARalpha, retinoid X receptor alpha (RXRalpha), was down-regulated in both cytoplasm and nucleus of A549 cells upon atRA addition."}, {"pubmed": 26848712, "text": "RARalpha regulates Arp2/3-mediated actin cytoskeletal dynamics through a non-genomic signaling pathway"}, {"pubmed": 26969398, "text": "down-regulation of the level of RAR alpha leads to increased expression of VDR in acute myeloid leukemia."}, {"pubmed": 27030546, "text": "Suggest a novel role of PCGF2 in arsenic trioxide-mediated degradation of PML-RARA that PCGF2 might act as a negative regulator of UBE2I via direct interaction."}, {"pubmed": 27052408, "text": "Data suggest that hematopoietically expressed homeobox protein (HHEX) downmodulation by promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein (PML-RARalpha) is a key event during acute promyelocytic leukemia (APL) pathogenesis."}, {"pubmed": 27306217, "text": "Low expression of RARalpha was independently associated with worse progression-free survival following platinum-based chemotherapy of advanced Non-small cell lung cancer."}, {"pubmed": 27419624, "text": "Silencing of PML-RAR and RARalpha2 results in similar increases in the constitutive expression of several granulocytic differentiation markers."}, {"pubmed": 27486764, "text": "Findings reveal a previously unrecognized role of c-Myc as a potential ceRNA for PML/RARalpha in acute promyelocytic leukemia."}, {"pubmed": 27499693, "text": "r study demonstrated that ATRA cound promote differentiation while inhibit proliferation of acute promyelocytic leukemia NB4 cells via activating p38a protein after recruiting p38a-combinded NLS-RARa, while NLS-RARa could inhibit the effects of ATRA in the process."}, {"pubmed": 27591797, "text": "It has been shown that the AP-1 family member JunB and retinoic acid receptor alpha (RARa) mediate catalase transcriptional activation and repression, respectively, by controlling chromatin remodeling through a histone deacetylases-dependent mechanism."}, {"pubmed": 27626703, "text": "Our findings unveil a novel essential oncogenic activity of PML/RARA in Acute promyelocitic leukemia"}, {"pubmed": 27840989, "text": "overexpression of NLS-RARalpha promoted the proliferation of APL cells and inhibited their differentiation via the PI3K/AKT signaling pathway."}, {"pubmed": 27872498, "text": "findings showed that the IRF2BP2-RARalpha fusion has the capacity to transform primary hematopoietic stem/progenitor cells and induced an ATRA-responsive acute promyelocytic leukemia (APL); this provides further evidence that formation of RARA fusion genes represent disease-defining mutations in APL pathogenesis"}, {"pubmed": 28035062, "text": "Demonstrate that RARalpha was frequently elevated in gastric carcinoma and exerted oncogenic properties via positive feedback loop of IL-1beta/Akt/RARalpha/Akt signaling."}, {"pubmed": 28129653, "text": "Data suggest that the binding of Z-10 to RXRalpha inhibited the interaction of RXRalpha with PML-RARalpha, leading to Z-10's selective induction of PML-RARalpha degradation."}, {"pubmed": 28370539, "text": "The data demonstrate that RARalpha drives integrin beta7-dependent adhesion and CCR9-mediated chemotaxis in CTCL cells."}, {"pubmed": 28412739, "text": "RARA drives cyclin-dependent kinase expression, G1-S transition, and cell growth in T-cell lymphoma."}, {"pubmed": 28416638, "text": "High RARA expression is associated with acute myeloid leukemia."}, {"pubmed": 28692043, "text": "Dual small interfering RNA (siRNA) silencing of RARalpha and RARgamma reversed RA blockade of P4-induced CK5. Using promoter deletion analysis, we identified a region 1.1 kb upstream of the CK5 transcriptional start site that is necessary for P4 activation and contains a putative progesterone response element (PRE"}, {"pubmed": 28766684, "text": "These results therefore indicate that EGCG targets PML/RARalpha oncoprotein for degradation and potentiates differentiation of promyelocytic leukemia cells in combination with ATRA via PTEN."}, {"pubmed": 28838264, "text": "PML and RARA breakpoint translocation is associated with acute promyelocytic leukemia."}, {"pubmed": 29119395, "text": "The level of RARalpha gene expression as a potential prognostic factor in the pathogenesis of multiple myeloma."}, {"pubmed": 29237593, "text": "Recurrent STAT3-RARA fusion is associated with acute promyelocytic leukemia lacking t(15;17)(q22;q12)/PML-RARA"}, {"pubmed": 29378601, "text": "Semiquantitative and quantitative analyses of the markers RARA and CRABP2 indicate their potential as biomarkers for tumor progression and their participation in nephroblastoma tumorigenesis"}, {"pubmed": 29530751, "text": "RARA and RARG gene downregulation associated with EZH2 mutation in acute promyelocytic-like morphology leukemia"}, {"pubmed": 29543331, "text": "in response to RA, TRIM24 serves as an adapter linking RARalpha to the proteasome for its degradation. In addition, TRIM24 and the proteasome are recruited with RARalpha to the promoters of target genes and thus are inherently linked to RARalpha transcriptional activity."}, {"pubmed": 29921692, "text": "Our results demonstrate that the majority of RARA-negative acute promyelocytic leukemia (APL) have RARB translocations, thereby forming a novel, distinct subgroup of APL. TBL1XR1-RARB as an oncogenic protein exerts effects similar to those of PML-RARA, underpinning the importance of retinoic acid pathway alterations in the pathogenesis of APL."}, {"pubmed": 30155836, "text": "RARalpha contributed to the malignancy of Esophageal Carcinoma."}, {"pubmed": 30237272, "text": "Alternative RARA or RARG gene fusions are associated with acute promyelocytic leukemia."}, {"pubmed": 30320491, "text": "Our findings reveal a previously unidentified mechanism, by which PML-RARalpha interferes with erythropoiesis through directly targeting and transrepressing LMO2 expression in the development of acute myeloid leukaemia (AML)."}, {"pubmed": 30421475, "text": "Despite the rarity of acute promyelocytic leukemia (APL) cases with an atypical PML/RARA fusion, our study indicates that an integrated laboratory approach, employing several diagnostic techniques is crucial to timely diagnose APL. This approach allows prompt initiation of specific targeted treatment and reliable MRD monitoring in atypical APL cases."}, {"pubmed": 30552662, "text": "BRD4 and PML/RARalpha co-existed on the same regulatory regions of their target genes. Hence, the study showed a new discovery of the interaction of BRD4 and PML/RARalpha, as well as the decline of PML/RARalpha expression in NB4 cells, under JQ1 treatment."}, {"pubmed": 30601638, "text": "The results of study demonstrate that increased level of expression in the first instance of isoform RARa in combination with hyper-expression of isoform RARbeta but not RARa can have unfavorable significance in case of evaluation of response to medicinal therapy and prognosis of total survival in patients with multiple melanoma."}, {"pubmed": 30674964, "text": "chromatin immunoprecipitation studies revealed the presence of RARalpha, RXRalpha and the lysine acetyl transferase PCAF in AGAP2 promoter."}, {"pubmed": 30695588, "text": "increased expression of ALDH1A1-RDH10-RARalpha- PPARbeta/delta pattern could be considered as adverse prognostic factor associated with a higher concentration of paraprotein and worst overall survival of patients with newly diagnosed multiple myeloma."}, {"pubmed": 30824184, "text": "PML S214L mutation on PML-retinoic acid receptor alpha showed \"cross-resistance\" to all-trans retinoic acid. Therapy-responsive changes of PML body ultrastructure were absent in S214L mutant."}, {"pubmed": 31126665, "text": "we summarize all variant translocations, their key features, their leukemogenic potential as well as recent advances in studies of PLZF-RARalpha-associated APL. Basic pathogenic differences between classical APL and PLZF-RARalpha-associated APL are further discussed"}, {"pubmed": 31190129, "text": "Serum VA concentration and the RARalpha expression pattern are abnormal in the rectum in ARM and may contribute to the ENS maldevelopment in ARM."}, {"pubmed": 31654721, "text": "NLS-RARalpha contributes to differentiation block and increased leukemogenic potential in vivo."}, {"pubmed": 32393309, "text": "Chromatin topology reorganization and transcription repression by PML-RARalpha in acute promyeloid leukemia."}, {"pubmed": 32475642, "text": "NLS-RARalpha blocks cell differentiation by inhibiting the retinoic acid signalling pathway."}, {"pubmed": 32735792, "text": "No prognostic significance of normalized copy number of PML-RARA transcript at diagnosis in patients with acute promyelocytic leukemia."}, {"pubmed": 32854112, "text": "A PML/RARalpha direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia."}, {"pubmed": 33120845, "text": "Does acute promyelocytic leukemia patient with the STAT5B/RARa fusion gene respond well to decitabine?: A case report and literature review."}, {"pubmed": 33255664, "text": "Microfluidic-Based Detection of AML-Specific Biomarkers Using the Example of Promyelocyte Leukemia."}, {"pubmed": 33647291, "text": "Structural Insights into the Interaction of the Intrinsically Disordered Co-activator TIF2 with Retinoic Acid Receptor Heterodimer (RXR/RAR)."}, {"pubmed": 33935126, "text": "Impact of RARalpha and miR-138 on retinoblastoma etoposide resistance."}, {"pubmed": 34042280, "text": "Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia."}, {"pubmed": 34117212, "text": "A novel fusion protein TBLR1-RARalpha acts as an oncogene to induce murine promyelocytic leukemia: identification and treatment strategies."}, {"pubmed": 34236496, "text": "Acute promyelocytic leukemia derived extracellular vesicles conserve PML-RARalpha transcript from storage-inflicted degradation: a stable diagnosis tool in APL patients."}, {"pubmed": 34292881, "text": "Signaling through retinoic acid receptors is essential for mammalian uterine receptivity and decidualization."}, {"pubmed": 35622143, "text": "PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As2O3 by stabilizing oncoprotein PML-RARalpha."}, {"pubmed": 36216898, "text": "Hyperthermia promotes degradation of the acute promyelocytic leukemia driver oncoprotein ZBTB16/RARalpha."}, {"pubmed": 36759620, "text": "Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia."}, {"pubmed": 38418133, "text": "Clinical Relevance of Differential RARalpha and PPARbeta/delta Expression in Myelodysplastic Syndromes."}, {"pubmed": 38648485, "text": "PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells."}], "genomic_pos": {"chr": "17", "end": 40357643, "ensemblgene": "ENSG00000131759", "start": 40309180, "strand": 1}, "genomic_pos_hg19": {"chr": "17", "end": 38513094, "start": 38465444, "strand": 1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0000122", "qualifier": "involved_in", "term": "negative regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001657", "qualifier": "involved_in", "term": "ureteric bud development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001843", "qualifier": "involved_in", "term": "neural tube closure"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001889", "qualifier": "involved_in", "term": "liver development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002068", "qualifier": "involved_in", "term": "glandular epithelial cell development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0003417", "qualifier": "involved_in", "term": "growth plate cartilage development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006468", "pubmed": 16456540, "qualifier": "involved_in", "term": "protein phosphorylation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007281", "qualifier": "involved_in", "term": "germ cell development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007565", "qualifier": "involved_in", "term": "female pregnancy"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0008284", "pubmed": 20080953, "qualifier": "involved_in", "term": "positive regulation of cell population proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008285", "qualifier": "involved_in", "term": "negative regulation of cell population proliferation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0009755", "qualifier": "involved_in", "term": "hormone-mediated signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0017148", "qualifier": "involved_in", "term": "negative regulation of translation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021766", "qualifier": "involved_in", "term": "hippocampus development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030154", "qualifier": "involved_in", "term": "cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030850", "qualifier": "involved_in", "term": "prostate gland development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030853", "pubmed": 19917671, "qualifier": "involved_in", "term": "negative regulation of granulocyte differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0031076", "qualifier": "involved_in", "term": "embryonic camera-type eye development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0031641", "qualifier": "involved_in", "term": "regulation of myelination"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032355", "qualifier": "involved_in", "term": "response to estradiol"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032526", "pubmed": 17538076, "qualifier": "involved_in", "term": "response to retinoic acid"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032689", "pubmed": 18416830, "qualifier": "involved_in", "term": "negative regulation of type II interferon production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032720", "pubmed": 18416830, "qualifier": "involved_in", "term": "negative regulation of tumor necrosis factor production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032736", "pubmed": 18416830, "qualifier": "involved_in", "term": "positive regulation of interleukin-13 production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032753", "pubmed": 18416830, "qualifier": "involved_in", "term": "positive regulation of interleukin-4 production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032754", "pubmed": 18416830, "qualifier": "involved_in", "term": "positive regulation of interleukin-5 production"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0033189", "qualifier": "involved_in", "term": "response to vitamin A"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0034097", "qualifier": "involved_in", "term": "response to cytokine"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035264", "qualifier": "involved_in", "term": "multicellular organism growth"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0042789", "pubmed": 1310351, "qualifier": "involved_in", "term": "mRNA transcription by RNA polymerase II"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0042789", "pubmed": 9430642, "qualifier": "involved_in", "term": "mRNA transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042981", "qualifier": "involved_in", "term": "regulation of apoptotic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043277", "pubmed": 19628791, "qualifier": "involved_in", "term": "apoptotic cell clearance"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045471", "qualifier": "involved_in", "term": "response to ethanol"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045630", "pubmed": 18416830, "qualifier": "involved_in", "term": "positive regulation of T-helper 2 cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045666", "qualifier": "involved_in", "term": "positive regulation of neuron differentiation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045787", "pubmed": 20080953, "qualifier": "involved_in", "term": "positive regulation of cell cycle"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045892", "pubmed": 20080953, "qualifier": "involved_in", "term": "negative regulation of DNA-templated transcription"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045893", "pubmed": [18845237, 19850744, 20080953], "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045893", "pubmed": 19628791, "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045944", "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": [9430642, 19850744, 19917671, 21131358], "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045944", "pubmed": 20080953, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045944", "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048167", "qualifier": "involved_in", "term": "regulation of synaptic plasticity"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0048384", "qualifier": "involved_in", "term": "retinoic acid receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0048384", "pubmed": [2825025, 19917671], "qualifier": "involved_in", "term": "retinoic acid receptor signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0048384", "pubmed": 17538076, "qualifier": "involved_in", "term": "retinoic acid receptor signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0051099", "pubmed": 20080953, "qualifier": "involved_in", "term": "positive regulation of binding"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0055012", "qualifier": "involved_in", "term": "ventricular cardiac muscle cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060010", "qualifier": "involved_in", "term": "Sertoli cell fate commitment"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060173", "qualifier": "involved_in", "term": "limb development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060324", "qualifier": "involved_in", "term": "face development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060534", "qualifier": "involved_in", "term": "trachea cartilage development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060591", "qualifier": "involved_in", "term": "chondroblast differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0061037", "qualifier": "involved_in", "term": "negative regulation of cartilage development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071222", "qualifier": "involved_in", "term": "cellular response to lipopolysaccharide"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0071300", "pubmed": 28122350, "qualifier": "involved_in", "term": "cellular response to retinoic acid"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071391", "pubmed": 20080953, "qualifier": "involved_in", "term": "cellular response to estrogen stimulus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1901532", "qualifier": "involved_in", "term": "regulation of hematopoietic progenitor cell differentiation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1902894", "pubmed": 28122350, "qualifier": "involved_in", "term": "negative regulation of miRNA transcription"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0000785", "pubmed": [17363140, 21131358], "qualifier": "part_of", "term": "chromatin"}, {"evidence": "ISA", "gocategory": "CC", "id": "GO:0000785", "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": [18845237, 19917671, 20080953], "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IPI", "gocategory": "CC", "id": "GO:0005667", "pubmed": [9430642, 10698945, 20543827, 21152046], "qualifier": "part_of", "term": "transcription regulator complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005730", "qualifier": "located_in", "term": "nucleolus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 19850744, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 2825025, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0015629", "qualifier": "located_in", "term": "actin cytoskeleton"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0030425", "qualifier": "located_in", "term": "dendrite"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0032991", "pubmed": [19917671, 20080953], "qualifier": "part_of", "term": "protein-containing complex"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0048471", "qualifier": "located_in", "term": "perinuclear region of cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0090575", "pubmed": 1310351, "qualifier": "part_of", "term": "RNA polymerase II transcription regulator complex"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0090575", "pubmed": 9430642, "qualifier": "part_of", "term": "RNA polymerase II transcription regulator complex"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0000900", "qualifier": "enables", "term": "mRNA regulatory element binding translation repressor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000977", "pubmed": 19917671, "qualifier": "enables", "term": "RNA polymerase II transcription regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000978", "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000978", "pubmed": [20080953, 21131358], "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0000978", "pubmed": 28122350, "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "ISA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IMP", "id": "GO:0001217", "pubmed": 28122350, "qualifier": "enables", "term": "DNA-binding transcription repressor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0001223", "pubmed": 17641689, "qualifier": "enables", "term": "transcription coactivator binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001972", "pubmed": 2825025, "qualifier": "enables", "term": "retinoic acid binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003682", "pubmed": 20080953, "qualifier": "enables", "term": "chromatin binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003700", "pubmed": [18922886, 20413580], "qualifier": "enables", "term": "DNA-binding transcription factor activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004879", "qualifier": "enables", "term": "nuclear receptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004879", "pubmed": [2825025, 21131358], "qualifier": "enables", "term": "nuclear receptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005102", "pubmed": 19628791, "qualifier": "enables", "term": "signaling receptor binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [9653119, 16189514, 16456540, 16606617, 16769902, 17363140, 17560333, 17641689, 18048326, 19345331, 19850744, 19917671, 19934264, 20080953, 20133701, 20211142, 20543827, 21478865, 21516116, 21988832, 22056876, 22351778, 23518351, 24819975, 25036637, 25241761, 25303530, 25416956, 26871637, 29892012, 31515488, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0008270", "qualifier": "enables", "term": "zinc ion binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019899", "pubmed": [9628876, 12039952], "qualifier": "enables", "term": "enzyme binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019904", "pubmed": 20413580, "qualifier": "enables", "term": "protein domain specific binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0031490", "pubmed": 19917671, "qualifier": "enables", "term": "chromatin DNA binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0042826", "qualifier": "enables", "term": "histone deacetylase binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0043422", "pubmed": 16417524, "qualifier": "enables", "term": "protein kinase B binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0044323", "pubmed": 19917671, "qualifier": "enables", "term": "retinoic acid-responsive element binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0048027", "qualifier": "enables", "term": "mRNA 5'-UTR binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0051018", "pubmed": 20215566, "qualifier": "enables", "term": "protein kinase A binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0051393", "pubmed": 22351778, "qualifier": "enables", "term": "alpha-actinin binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:1901363", "qualifier": "enables", "term": "heterocyclic compound binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990837", "pubmed": 28473536, "qualifier": "enables", "term": "sequence-specific double-stranded DNA binding"}]}, "homologene": {"genes": [[7955, 30680], [7955, 555364], [8364, 100038052], [9031, 395213], [9606, 5914], [9615, 480526], [9913, 534280], [10090, 19401], [10116, 24705]], "id": 20262}, "interpro": [{"desc": "Nuclear hormone receptor, ligand-binding domain", "id": "IPR000536", "short_desc": "Nucl_hrmn_rcpt_lig-bd"}, {"desc": "Zinc finger, nuclear hormone receptor-type", "id": "IPR001628", "short_desc": "Znf_hrmn_rcpt"}, {"desc": "Nuclear hormone receptor", "id": "IPR001723", "short_desc": "Nuclear_hrmn_rcpt"}, {"desc": "Retinoic acid receptor", "id": "IPR003078", "short_desc": "Retinoic_acid_rcpt"}, {"desc": "Zinc finger, NHR/GATA-type", "id": "IPR013088", "short_desc": "Znf_NHR/GATA"}, {"desc": "Nuclear hormone receptor-like domain superfamily", "id": "IPR035500", "short_desc": "NHR-like_dom_sf"}, {"desc": "Retinoic acid receptor, ligand-binding domain", "id": "IPR047158", "short_desc": "NR_LBD_RAR"}, {"desc": "Retinoic acid receptor, DNA-binding domain", "id": "IPR047159", "short_desc": "NR_DBD_RAR"}], "ipi": ["IPI00014923", "IPI00020071", "IPI00218375", "IPI00908598", "IPI00922641"], "map_location": "17q21.2", "name": "retinoic acid receptor alpha", "other_names": ["PML-DDX5-RARA fusion", "PML-DDX5-RARA fusion protein", "RAR-alpha", "nuclear receptor subfamily 1 group B member 1", "nucleophosmin-retinoic acid receptor alpha fusion protein NPM-RAR long form", "retinoic acid receptor alpha", "retinoic acid receptor, alpha polypeptide"], "pantherdb": {"HGNC": "9864", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "97856", "ortholog_type": "LDO", "panther_family": "PTHR24082", "taxid": 10090, "uniprot_kb": "P11416"}, {"RGD": "3534", "ortholog_type": "LDO", "panther_family": "PTHR24082", "taxid": 10116, "uniprot_kb": "A0A0G2JW78"}, {"Ensembl": "ENSGALG00000037935", "ortholog_type": "LDO", "panther_family": "PTHR24082", "taxid": 9031, "uniprot_kb": "Q90966"}, {"ZFIN": "ZDB-GENE-980526-72", "ortholog_type": "O", "panther_family": "PTHR24082", "taxid": 7955, "uniprot_kb": "Q7ZTI3"}, {"ZFIN": "ZDB-GENE-980526-284", "ortholog_type": "LDO", "panther_family": "PTHR24082", "taxid": 7955, "uniprot_kb": "Q90271"}, {"WormBase": "WBGene00003601", "ortholog_type": "O", "panther_family": "PTHR24082", "taxid": 6239, "uniprot_kb": "Q10902"}, {"WormBase": "WBGene00003606", "ortholog_type": "O", "panther_family": "PTHR24082", "taxid": 6239, "uniprot_kb": "Q20765"}, {"WormBase": "WBGene00006790", "ortholog_type": "O", "panther_family": "PTHR24082", "taxid": 6239, "uniprot_kb": "G5ECR9"}, {"WormBase": "WBGene00004786", "ortholog_type": "O", "panther_family": "PTHR24082", "taxid": 6239, "uniprot_kb": "P41830"}, {"WormBase": "WBGene00003675", "ortholog_type": "O", "panther_family": "PTHR24082", "taxid": 6239, "uniprot_kb": "Q9XUK7"}, {"FlyBase": "FBgn0000568", "ortholog_type": "O", "panther_family": "PTHR24082", "taxid": 7227, "uniprot_kb": "P13055"}], "uniprot_kb": "P10276"}, "pathway": {"biocarta": [{"id": "carm1pathway", "name": "transcription regulation by methyltransferase of carm1"}, {"id": "rarpathway", "name": "degradation of the rar and rxr by the proteasome"}, {"id": "rarrxrpathway", "name": "nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells"}], "kegg": [{"id": "hsa04659", "name": "Th17 cell differentiation - Homo sapiens (human)"}, {"id": "hsa04915", "name": "Estrogen signaling pathway - Homo sapiens (human)"}, {"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}, {"id": "hsa05202", "name": "Transcriptional misregulation in cancer - Homo sapiens (human)"}, {"id": "hsa05221", "name": "Acute myeloid leukemia - Homo sapiens (human)"}], "pid": [{"id": "retinoic_acid_pathway", "name": "Retinoic acid receptors-mediated signaling"}, {"id": "rxr_vdr_pathway", "name": "RXR and RAR heterodimerization with other nuclear receptor"}], "reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-2990846", "name": "SUMOylation"}, {"id": "R-HSA-3108232", "name": "SUMO E3 ligases SUMOylate target proteins"}, {"id": "R-HSA-383280", "name": "Nuclear Receptor transcription pathway"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-4090294", "name": "SUMOylation of intracellular receptors"}, {"id": "R-HSA-5362517", "name": "Signaling by Retinoic Acid"}, {"id": "R-HSA-5617472", "name": "Activation of anterior HOX genes in hindbrain development during early embryogenesis"}, {"id": "R-HSA-5619507", "name": "Activation of HOX genes during differentiation"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-9006931", "name": "Signaling by Nuclear Receptors"}, {"id": "R-HSA-9006936", "name": "Signaling by TGFB family members"}, {"id": "R-HSA-9616222", "name": "Transcriptional regulation of granulopoiesis"}, {"id": "R-HSA-9616222", "name": "Transcriptional regulation of granulopoiesis"}, {"id": "R-HSA-9839373", "name": "Signaling by TGFBR3"}, {"id": "R-HSA-9839394", "name": "TGFBR3 expression"}], "wikipathways": [{"id": "WP170", "name": "Nuclear receptors"}, {"id": "WP236", "name": "Adipogenesis"}, {"id": "WP299", "name": "Nuclear Receptors in Lipid Metabolism and Toxicity"}, {"id": "WP3658", "name": "Wnt-beta-catenin signaling pathway in leukemia"}, {"id": "WP4149", "name": "White fat cell differentiation"}, {"id": "WP4342", "name": "Vitamins A and D - action mechanisms"}, {"id": "WP5053", "name": "Development of ureteric collection system"}, {"id": "WP716", "name": "Vitamin A and carotenoid metabolism"}]}, "pdb": ["1DKF", "1DSZ", "3A9E", "3KMR", "3KMZ", "4DQM", "5K13", "6XWG", "7AOS", "7APO", "7QAA", "7WQQ"], "pfam": ["PF00104", "PF00105"], "pharmgkb": "PA34225", "pharos": {"target_id": 11691, "tdl": "Tclin"}, "pir": "A29491", "prosite": ["PS51030", "PS51843"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF255535", "relationship": "is"}, {"id": "GNF255536", "relationship": "is"}, {"id": "GNF255537", "relationship": "is"}, {"id": "GNF255538", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF162670", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF089437", "relationship": "is"}, {"id": "GNF089438", "relationship": "is"}, {"id": "GNF089439", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051920", "relationship": "is"}, {"id": "GNF056686", "relationship": "is"}, {"id": "GNF061478", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF062763", "relationship": "is"}, {"id": "GNF062764", "relationship": "is"}], "GNF_hs-pkinase_IDT-siRNA": {"id": "GNF165567", "relationship": "is"}, "GNF_hs_LentiORF-HA-MYC": {"id": "GNF282989", "relationship": "is"}, "GNF_hs_LentiORF-Jred": {"id": "GNF283916", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF012205", "relationship": "is"}, {"id": "GNF012206", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": [{"id": "GNF234621", "relationship": "is"}, {"id": "GNF284984", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF094064", "relationship": "is"}, {"id": "GNF133722", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000017.11", "NC_060941.1", "NG_027701.1"], "protein": ["NP_000955.1", "NP_001019980.1", "NP_001138773.1", "NP_001138774.1", "XP_005257609.1", "XP_005257610.1", "XP_005257611.1", "XP_011523397.1", "XP_011523398.1", "XP_047292462.1", "XP_047292463.1", "XP_047292464.1", "XP_054172813.1", "XP_054172814.1", "XP_054172815.1", "XP_054172816.1", "XP_054172817.1", "XP_054172818.1", "XP_054172819.1"], "rna": ["NM_000964.4", "NM_001024809.4", "NM_001033603.1", "NM_001145301.3", "NM_001145302.3", "XM_005257552.6", "XM_005257553.2", "XM_005257554.2", "XM_011525095.2", "XM_011525096.2", "XM_047436506.1", "XM_047436507.1", "XM_047436508.1", "XM_054316838.1", "XM_054316839.1", "XM_054316840.1", "XM_054316841.1", "XM_054316842.1", "XM_054316843.1", "XM_054316844.1"], "translation": [{"protein": "XP_047292462.1", "rna": "XM_047436506.1"}, {"protein": "XP_011523397.1", "rna": "XM_011525095.2"}, {"protein": "XP_047292464.1", "rna": "XM_047436508.1"}, {"protein": "NP_001138773.1", "rna": "NM_001145301.3"}, {"protein": "XP_054172817.1", "rna": "XM_054316842.1"}, {"protein": "XP_054172813.1", "rna": "XM_054316838.1"}, {"protein": "XP_005257609.1", "rna": "XM_005257552.6"}, {"protein": "NP_001019980.1", "rna": "NM_001024809.4"}, {"protein": "XP_054172815.1", "rna": "XM_054316840.1"}, {"protein": "XP_005257610.1", "rna": "XM_005257553.2"}, {"protein": "XP_054172818.1", "rna": "XM_054316843.1"}, {"protein": "NP_000955.1", "rna": "NM_000964.4"}, {"protein": "XP_054172816.1", "rna": "XM_054316841.1"}, {"protein": "XP_054172819.1", "rna": "XM_054316844.1"}, {"protein": "NP_001138774.1", "rna": "NM_001145302.3"}, {"protein": "XP_047292463.1", "rna": "XM_047436507.1"}, {"protein": "XP_054172814.1", "rna": "XM_054316839.1"}, {"protein": "XP_005257611.1", "rna": "XM_005257554.2"}, {"protein": "XP_011523398.1", "rna": "XM_011525096.2"}]}, "reporter": {"HG-U133_Plus_2": ["1565358_at", "203749_s_at", "203750_s_at", "211605_s_at", "216300_x_at"], "HG-U95Av2": "1337_s_at", "HTA-2_0": "TC17000496.hg.1", "HuEx-1_0": "3720921", "HuGene-1_1": "8007084", "HuGene-2_1": "16834071"}, "summary": "This gene represents a nuclear retinoic acid receptor. The encoded protein, retinoic acid receptor alpha, regulates transcription in a ligand-dependent manner. This gene has been implicated in regulation of development, differentiation, apoptosis, granulopoeisis, and transcription of clock genes. Translocations between this locus and several other loci have been associated with acute promyelocytic leukemia. Alternatively spliced transcript variants have been found for this locus.[provided by RefSeq, Sep 2010].", "symbol": "RARA", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1366536"}, "unigene": "Hs.654583", "uniprot": {"Swiss-Prot": "P10276", "TrEMBL": ["Q6I9R7", "A8MUP8", "F1D8N9", "A8K840", "J3KSJ4", "J3QRM2"]}, "wikipedia": {"url_stub": "Retinoic acid receptor alpha"}}